论文部分内容阅读
我们用重组白细胞介素 2 (ｒＩＬ 2 )激活骨髓 (ＡＢＭ)自体移植和移植后应用ｒＩＬ 2治疗白血病和非霍奇金淋巴瘤 ,在临床上取得理想的疗效[1,2 ] 。现就影响移植后的长期生存进行多因素分析 ,报告如下。病例和方法1 病例 我院 1993年 6月～ 1999年 1月接受ＡＢＭ移植的患者
We used rIL 2-activated bone marrow (ABM) autologous transplantation and transplantation of rIL 2 after treatment of leukemia and non-Hodgkin’s lymphoma, and achieved the desired clinical effect [1,2]. Now affect the long-term survival after transplantation multivariate analysis, the report is as follows. Cases and methods 1 cases in our hospital from June 1993 to January 1999 patients undergoing ABM transplantation